# A Study to Assess the Safety of ARGX-109 in Healthy Volunteers

> **NCT06799416** · PHASE1 · COMPLETED · sponsor: **argenx** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** ARGX-109
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06799416
- **Lead sponsor:** argenx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-14
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-08-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799416, "A Study to Assess the Safety of ARGX-109 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06799416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*